Abstract:Background: Offspring exposed to gestational diabetes mellitus (GDM) are at a high risk for metabolic diseases. The mechanisms behind the association between offspring exposed to GDM in utero and an increased risk of health consequences later in life remain unclear. The aim of this study was to clarify the changes in methylation levels in the foetuses of women with GDM and to explore the possible mechanisms linking maternal GDM with a high risk of metabolic diseases in offspring later in life. Methods: A genome-wide comparative methylome analysis on the umbilical cord blood of infants born to 30 women with GDM and 33 women with normal pregnancy was performed using Infinium HumanMethylation 450 BeadChip assays. A quantitative methylation analysis of 18 CpG dinucleotides was verified in the validation umbilical cord blood samples from 102 newborns exposed to GDM and 103 newborns who experienced normal pregnancy by MassARRAY EpiTYPER. Results: A total of 4485 differentially methylated sites (DMSs), including 2150 hypermethylated sites and 2335 hypomethylated sites, with a mean beta-value difference of >0.05, were identified by the 450k array. Good agreement was observed between the massarray validation data and the 450k array data (R-2 > 0.99; P < 0.0001). Thirty-seven CpGs (representing 20 genes) with a b-value difference of > 0.15 between the GDM and healthy groups were identified and showed potential as clinical biomarkers for GDM. "hsa04940: Type I diabetes mellitus" was the most significant Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, with a P-value = 3.20E-07 and 1.36E-02 in the hypermethylated and hypomethylated genepathway enrichment analyses, respectively. In the Gene Ontology (GO) pathway analyses, immune MHC (major histocompatibility complex)-related pathways and neuron development-related pathways were significantly enriched. Conclusions: Our results suggest that GDM has epigenetic effects on genes that are preferentially involved in the Type I diabetes mellitus pathway, immune MHC-related pathways and neuron development-related pathways, with consequences on fetal growth and development, and provide supportive evidence that DNA methylation is involved in fetal metabolic programming. (C) 2018 Elsevier B.V. All rights reserved.

LGA Infants Display Early Catch Down Growth in Length and Weight Without Epigenetic Changes

Infants Born Large-for-gestational-age Display Slower Growth in Early Infancy, but No Epigenetic Changes at Birth

Altered DNA methylation in neonates born large-for-gestational-age is associated with cardiometabolic risk in children.

Investigation of Character Patterns of Early Growth in Infants with Different Birth Weights

Childhood Growth Trajectories of Etiological Subgroups of Large for Gestational Age Newborns.

Effect of Maternal Lipid Profile, C-peptide, Insulin, and HBA1c Levels During Late Pregnancy on Large-for-gestational Age Newborns

Newborn DNA methylation age differentiates long-term weight trajectory: The Boston Birth Cohort

Differences of DNA Methylation Patterns in the Placenta of Large for Gestational Age Infant

Newborn DNA methylation age differentiates long-term weight trajectories: the Boston Birth Cohort

Cord Blood C-peptide, Insulin, HbA1c, and Lipids Levels in Small- and Large-for-Gestational-Age Newborns

Childhood Health Outcomes in Term, Large-for-Gestational-Age Babies with Different Postnatal Growth Patterns.

Epigenome-wide meta-analysis of blood DNA methylation in newborns and children identifies numerous loci related to gestational age

Genome-wide DNA Methylation Profiling in Infants Born to Gestational Diabetes Mellitus

Epigenome-850K-wide Profiling Reveals Peripheral Blood Differential Methylation in Term Low Birth Weight.

Increased Methylation at Differentially Methylated Region of GNASin Infants Born to Gestational Diabetes

Genome-wide DNA methylation changes in placenta tissues associated with small for gestational age newborns; cohort study in the Chinese population.

Igf-Ii Expression and Methylation in Small for Gestational Age Infants

Umbilical cord DNA methylation is associated with body mass index trajectories from birth to adolescence

Genome-wide Placental DNA Methylations in Fetal Overgrowth and Associations with Leptin, Adiponectin and Fetal Growth Factors

Growth Status of Full-Term Infants with Different Sizes for Gestational Age During the First Year of Life

Abundances of Placental Imprinted Genes CDKN1C, PHLDA2 and IGF-2 Are Related to Low Birth Weight and Early Catch-Up Growth in Full-Term Infants Born Small for Gestational Age.